Caffeine metabolism in premature infants

Journal of Clinical Pharmacology

Volumn 41, Issue 6, 2001, Pages 620-627

  Al Alaiyan, Saleh ^a   Al Rawithi, Saleh ^a   Raines, Dale ^a   Yusuf, Ahmed ^a   Legayada, Erlinda ^a   Shoukri, Mohamed M ^a   El Yazigi, Adnan ^a  

^a King Faisal Specialist Hospital and Research Centre   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLURIC ACID; 1 METHYLXANTHINE; 1,3 DIMETHYLURIC ACID; 1,3,7 TRIMETHYLURIC ACID; 1,7 DIMETHYLURIC ACID; 3 METHYLXANTHINE; 3,7 DIMETHYLURIC ACID; 5 ACETAMIDO 6 FORMYLAMINO 3 METHYLURACIL; 5 ACETYLAMINO 5 AMINO 6 FORMYLAMINO 3 METHYLURACIL; 7 METHYLURIC ACID; 7 METHYLXANTHINE; ACYLTRANSFERASE; CAFFEINE; CAFFEINE DERIVATIVE; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 ISOENZYME; PARAXANTHINE; THEOBROMINE; THEOPHYLLINE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

AGE; APNEA; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DRUG HYDROXYLATION; DRUG METABOLISM; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; PREMATURITY; SEX DIFFERENCE;

AGE FACTORS; BIRTH WEIGHT; BODY WEIGHT; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; SAUDI ARABIA; SEX CHARACTERISTICS;

EID: 0035008176     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700122010500     Document Type: Article

References (27)

1. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant
2. Products of metabolism of caffeine
3. Effects of allopurinol on caffeine disposition in man
4. Polymorphic N-acetylation of a caffeine metabolite
5. Variability in caffeine metabolism
6. Caffeine metabolism in cystic fibrosis: Enhanced xanthine oxidase activity
7. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: Coincidence with plasma clearance and breath test
8. A simple test for acetylator phenotype using caffeine
9. A simplified and rapid test for acetylator phenotyping by use of the peak height ratio of two urinary caffeine metabolites
10. Caffeine as an indicator of metabolic functions of microsomal liver enzymes
11. Use of salivary levels to predict clearance of caffeine in patients with cystic fibrosis
12. Urinary caffeine metabolites in man: Age-dependent changes and pattern in various clinical situations
13. 2 breath test: Dose response and route of N-demethylation in smokers and non-smokers
14. Pharmacokinetic aspects of caffeine in premature infants with apnoea
15. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity
16. Maturation of caffeine metabolic pathways in infancy
17. Population pharmacokinetics of caffeine in neonates and young infants
18. Age dependence of activity of polymorphic N-acetyltransferase in fetal human liver was estimated and compared with the hepatic enzymes of adults
19. Maturation of caffeine elimination in infancy
20. 2 breath test
21. Caffeine acetylator phenotyping during maturation in infants
22. Maturation of AFMU excretion in infants
23. Standards of laboratory practice: Theophylline and caffeine monitoring
24. Salivary clearance and urinary metabolic pattern of caffeine in healthy children and in pediatric patients with hepatocellular diseases
25. Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test
26. Caffeine and theophylline metabolism in newborn and adult human hepatocytes; comparison with adult rat hepatocytes
27. Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations